Journal Mobile Options
Table of Contents
Vol. 25, No. 4, 2005
Issue release date: October 2005
Neuroepidemiology 2005;25:163–175

The Rush Memory and Aging Project: Study Design and Baseline Characteristics of the Study Cohort

Bennett D.A. · Schneider J.A. · Buchman A.S. · Mendes de Leon C. · Bienias J.L. · Wilson R.S.
aRush Alzheimer’s Disease Center, Departments of bNeurological Sciences, cPathology, dPreventive Medicine, eInternal Medicine, and fRush Institute for Healthy Aging, and gPsychology, Rush University Medical Center, Chicago, Ill., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


The long-term objective of the Rush Memory and Aging Project is to identify the postmortem indices linking genetic and environmental risk factors to the development of Alzheimer’s disease (AD). The overall study design involves a detailed assessment of risk factors for AD in older persons without known dementia who agree to annual clinical evaluation and organ donation at the time of death. In contrast to other clinical-pathologic studies which are conducted on special populations, the Rush Memory and Aging Project enrolled a cohort with much greater diversity in terms of educational attainment, in addition to gender, race, and ethnicity. From September of 1997 through April of 2005, more than 1,000 older persons without known dementia from more than 30 residential facilities across the Chicago metropolitan area agreed to participate. Their mean age was 81 years, about a third had 12 or fewer years of education, a third were men, and about 10% were members of a racial or ethnic minority group. More than 950 already have completed their baseline clinical evaluation.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA: Alzheimer’s disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 2003;60:1119–1122.
  2. Bloom BS, de Pouvourville N, Straus WL: Cost of illness of Alzheimer’s disease: how useful are current estimates? Gerontologist 2003;43:158–164.
  3. Brookmeyer R, Gray S, Kawas C: Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998;88:1337–1342.
  4. Sloane PD, Zimmerman S, Suchindran C, et al: The public health impact of Alzheimer’s disease, 2000–2050: potential implication of treatment advances. Annu Rev Public Health 2002;23:213–221.
  5. Bennett DA, Wilson RS, Schneider JA, et al: Apolipoprotein E4 allele, Alzheimer’s disease pathology, and the clinical expression of AD. Neurology 2003;60:246–252.
  6. Bennett DA, Schneider JA, Wilson RS, Bienias JL, Berry-Kravis E, Arnold SE: Amyloid mediates the association of apolipoprotein Eε4 to level of cognitive function in older persons. J Neurol Neurosurg Psychiatry 2005;76: in press.
  7. Knopman DS, Parisi JE, Salviati A, et al: Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol 2003;62:1087–1095.
  8. Morris JC, Storandt M, Miller JP, et al: Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001;58:397–405.
  9. Green MS, Kaye JA, Ball MJ: The Oregon brain aging study: neuropathology accompanying healthy aging in the oldest old. Neurology 2000;54:105–113.
  10. Schmitt FA, Wetherby MM, Wekstein DR, Dearth CM, Markesbery WR: Brain donation in normal aging: procedures, motivations, and donor characteristics from the Biologically Resilient Adults in Neurological Studies (BRAiNS) Project. Gerontologist 2001;41:716–722.
  11. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA: Cerebral infarctions and the likelihood of dementia from Alzheimer’s disease pathology. Neurology 2004;62:1148–1155.
  12. Bennett DA, Wilson RS, Schneider JA, et al: Education modifies the relation of AD pathology to cognitive function in older persons. Neurology 2003;60:1909–1915.
  13. Bennett DA, Wilson RS, Schneider JA, Bienias JL, Arnold SE: Cerebral infarctions and the relation of depressive symptoms to level of cognitive function in older persons. Am J Geriatr Psychiatry 2004;12:211–219.
  14. Wilson RS, Evans DA, Bienias JL, Mendes de Leon CF, Schneider JA, and Bennett DA: Proneness to psychological distress and risk of Alzheimer’s disease. Neurology 2003;61:1579–1585.
  15. Katzman R, Terry R, DeTeresa R, et al: Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 1988;23:138–441.
  16. Scarmeas N, Stern Y: Cognitive reserve: implications for diagnosis and prevention of Alzheimer’s disease. Curr Neurol Neurosci Rep 2004;4:374–380.
  17. Staff RT, Murray AD, Deary IJ, Whalley LJ: What provides cerebral reserve? Brain 2004;127:1191–1199.
  18. Lindsted KD, Fraser GE, Steinkohl M, Beeson WL: Healthy volunteer effect in a cohort study: temporal resolution in the Adventist Health Study. J Clin Epidemiol 1996;49:783–790.
  19. McKhann G, Drachmann D, Folstein M, Katzman R, Price D, Stadlan E: Clinical diagnosis of Alzheimer’s disease. Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939.
  20. Bennett DA, Wilson RS, Schneider JA, et al: Natural history of mild cognitive impairment in older persons. Neurology 2002;59:198–205.
  21. Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS: Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology 2005;64:834–841.
  22. Adams HP Jr, Bendixen BH, Kappelle LJ, et al: Subtypes of acute ischemic stroke definitions for multi-center clinical trials. Stroke 1993;24:35–41.
  23. Roman GC, Tatemichi TK, Erkinjuntti T, et al: Vascular dementia: Diagnostic criteria for research studies – Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250–260.
  24. Langston JW, Widner H, Goetz CGT, et al: Core Assessment Program for Intracerebral Transplantations (CAPIT). Mov Disord 1992;7:2–13.
  25. McKeith IG, Perry EK, Perry RH: Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies. Neurology 1999;53:902-905.
  26. Robins LN, Helzer JE, Ratcliff KS, Seyfried W: Validity of the Diagnostic Interview Schedule. II. DSM-III diagnoses. Psychol Med 1982;12:855–870.
  27. Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA: Parkinsonian-like signs and risk of incident Alzheimer’s disease in older persons. Arch Neurol 2003;60:539–544.
  28. Wilson RS, Schneider JA, Bienias JL, Arnold S, Evans DA, Bennett DA: Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons. Neurology 2003;61:1102–1108.
  29. Harik-Khan, RI, Wise RA, Fozard JL: Determinants of maximal inspiratory pressure. The Baltimore Longitudinal Study of Aging. Am J Respir Crit Care Med 1998;158:1459–1464.
  30. Folstein MF, Folstein SE, McHugh PR: ‘Mini-Mental State’: A practical method for grading the mental state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
  31. Wechsler D: Wechsler Memory Scale-Revised Manual. New York, Psychological Corporation, 1987.
  32. Albert MS, Smith LA, Scherr PA, et al: Use of brief cognitive tests to identify individuals in the community with clinically-diagnosed Alzheimer’s disease. Int J Neurosci 1991;57:167–178.
  33. Wilson RS, Beckett LA, Barnes LL, et al: Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging 2002;17:179–193.
  34. Morris J, Heyman A, Mohs, R, et al: The consortium to establish a registry for Alzheimer’s disease (CERAD). Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology 1989;39:1159–1165.
  35. Kaplan EF, Goodglass H, Weintraub S: The Boston Naming Test. Philadelphia, Lea & Febiger, 1983.
  36. Cooper JA, Sagar HJ: Incidental and intentional recall in Parkinson’s disease: An account based on diminished attentional resources. J Clin Exp Neuropsychol 1993;15:713–731.
  37. Smith A: Symbol Digit Modalities Test manual-revised. Los Angeles, Western Psychological, 1984.
  38. Ekstrom RB, French JW, Harman HH, Dermen D: Manual for the kit of factor-referenced cognitive tests. Princeton, Educational Testing Service, 1976.
  39. Trenerry MR, Crosson B, DeBoe J, Leber WR: The Stroop Neuropsychological Screening Test. Odessa, Psychological Assessment Resources, 1989.
  40. Benton AL, Varney N, et al: Visuospatial judgment – A clinical test. Arch Neurol 1978;35:364–367.
  41. Raven JC, Court JH, Raven J: Standard progressive matrices. Raven Manual, sect 3. Oxford, Oxford Psychologists Press, 1992.
  42. Goodglass H, Kaplan E: The Assessment of Aphasia and Related Disorders. Philadelphia, Lea & Febiger, 1972.
  43. Wilson RS, Barnes LL, Kreuger KR, Hoganson G, Bienias JL, Bennett DA: Early and late life cognitive activity and cognitive systems in old age. J Int Neuropsychol Soc, in press.
  44. Fleischman DA, Wilson RS, Bienias JL, Bennett DA: Parkinsonian signs and cognitive function in old age. J Int Neuropsychol Soc, in press.
  45. Bennett DA, Shannon KM, Beckett LA, Goetz CG, Wilson RS: Metric properties of nurses’ ratings of parkinsonian signs with a modified Unified Parkinson’s Disease Rating Scale. Neurology 1997;49:1580–1587.
  46. Bennett DA, Shannon KM, Beckett LA, Wilson RS: Dimensionality of parkinsonian signs in aging and Alzheimer’s disease. J Gerontol Med Sci 1999;54:M191–M196.
  47. Wilson RS, Bienias JL, Mendes de Leon CF, Evans DA, Bennett DA: Negative affect and mortality in older persons. Am J Epidemiol 2003;158:827–835.
  48. Tiffin J, Asher EJ: The Purdue Pegboard: Norms and studies of reliability and validity. J Appl Psychol 1948;32:234–247.

    External Resources

  49. Buchman AS, Wilson RS, Bienias JL, Bennett DA: Gender differences in motor performance of older persons. Geriatr Gerontol Int 2005;5:59–65.

    External Resources

  50. Wang CY, Olson SL, Protas EJ: Test-retest strength reliability: hand-held dynamometry in community-dwelling elderly fallers. Arch Phys Med Rehabil 2002;83:811–815.
  51. Katz S, Akpom C: A measure of primary sociobiological functions. Int J Health Serv 1976;6:493–508.
  52. Rosow I, Breslau N: A Guttman health scale for the aged. J Gerontol 1966;21:556–559.
  53. Lawton MP, Brody EM: Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179–186.
  54. Tinetti ME, Ginter SF: The nursing home life-space diameter: a measure of extent and frequency of mobility among nursing home residents. J Am Geriatric Soc 1990;38:1311–1315.
  55. Stalvey BT, Owsley C, Sloane ME, Ball K: The Life Space Questionnaire: A measure of the extent of mobility of older adults. J Appl Gerontol 1999;18:460–478.
  56. van Praag H, Kempermann G, Gage FH: Neural consequences of environmental enrichment. Nat Rev Neurosci 2000;1:191–198.
  57. Kramer AF, Bherer L, Colcombe SJ, Dong W, Greenough WT: Environmental influences on cognitive and brain plasticity during aging. J Gerontol A Biol Sci Med Sci 2004;59:M940–M957.
  58. Lazarov O, Robinson J, Tang YP, et al: Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 2005;120:701–713.
  59. Adlard PA, Perreau VM, Pop V, Cotman CW: Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer’s disease. J Neurosci 2005;25:4217–4221.
  60. Wilson RS, Scherr PA, Hoganson G, Bienias JL, Evans DA, Bennett DA: Early life socioeconomic status and late life risk of Alzheimer’s disease. Neuroepidemiology 2005;25:8–14.
  61. Richardson MT, Leon AS, Jacobs DR Jr, Ainsworth BE, Serfass R: Comprehensive evaluation of the Minnesota Leisure Time Physical Activity Questionnaire. J Clin Epidemiol 1994;47:271–281.
  62. Wilson RS, Mendes de Leon CF, Barnes LL, Schneider JA, Bienias JL, Evans DA, Bennett DA: Participation in cognitively stimulating activities and risk of AD. JAMA 2002;287:742–748.
  63. Mendes de Leon CF, Glass TA, Beckett LA, et al: Social networks and disability transitions across eight intervals of yearly data in the New Haven EPESE. J Gerontol Soc Sci 1999;54:162–172.
  64. Mendes de Leon CF, Glass TA, Berkman LF: Social engagement and disability in a community population of older adults: the New Haven EPESE. Am J Epidemiol 2003;157:633–642.
  65. de Jong Gierveld J, Kamphuis FH: The development of a Rasch-type loneliness scale. Appl Psychol Meas 1985;9:289–299.

    External Resources

  66. Kohout FJ, Berkman LF, Evans DA, Cornoni-Huntley J: Two shorter forms of the CES-D depression symptoms index. J Aging Health 1993;5:179–193.
  67. Radloff LS: The CES-D scale: a self report depression scale for research in the general population. Appl Psychol Meas 1977;1:385–401.

    External Resources

  68. Costa PT, McCrae RR: Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory (NEO-FFI) professional manual. Odessa, Psychological Assessment Resources, 1992.
  69. Ryff CD, Keyes CLM: The structure of psychological well-being revisited. J Personal Soc Psychol 1995;69:719–727.
  70. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA: Cerebral infarctions and the likelihood of dementia from Alzheimer’s disease pathology. Neurology 2004;62:1148–1155.
  71. Schneider JA, Bienias J, Gilley DW, Kvarnberg D, Mufson EJ, Bennett DA: Improved detection of neurofibrillary pathology in Alzheimer’s disease. J Histochem Cytochem 2002;50:99–106.
  72. Falke E, Nissanov J, Mitchell TW, Bennett DA, Trojanowski JQ, Arnold SE: Subicular dendritic arborization is decreased in Alzheimer’s disease and correlates with neurofibrillary tangle density. Am J Pathol 2003;163:1615–1621.
  73. Honer WG: Pathology of presynaptic proteins in Alzheimer’s disease: more than simple loss of terminals. Neurobiol Aging 2003;24:1047–1062.
  74. Wilson RS, Bennett DA, Bienias JL, et al: Cognitive activity and incident AD in a population-based sample of older persons. Neurology 2002;59:1910–1915.
  75. Abbott RD, White LR, Ross GW, Masaki KH, Curb JD, Petrovitch H: Walking and dementia in physically capable elderly men. JAMA 2004;292:1447–1453.
  76. Verghese J, Lipton RB, Katz MJ, et al: Leisure activities and the risk of dementia in the elderly. N Engl J Med 2003;348:2508–2516.
  77. Scarmeas N, Levy G, Tang MX, Manly J, Stern Y: Influence of leisure activity on the incidence of Alzheimer’s disease. Neurology 2001;57:2236–2242.
  78. Weuve J, Kang JH, Manson JE, Breteler MM, Ware JH, Grodstein F: Physical activity, including walking, and cognitive function in older women. JAMA 2004;292:1454–1461.
  79. Yaffe K, Barnes D, Nevitt M, Lui LY, Covinsky K: A prospective study of physical activity and cognitive decline in elderly women: women who walk. Arch Intern Med 2001;161:1703–1708.
  80. Podewils LJ, Guallar E, Kuller LH, et al: Physical activity, APOE genotype, and dementia risk: findings from the cardiovascular health cognition study. Am J Epidemiol 2005;161:639–651.
  81. Sayer AA, Syddall HE, Gilbody HJ, Dennison EM, Cooper C: Does sarcopenia originate in early life? Findings from the Hertfordshire cohort study. J Gerontol A Biol Sci Med Sci 2004;59:M930–M934.
  82. Gill TM, Allore H, Guo Z: The deleterious effects of bed rest among community-living older persons. J Gerontol A Biol Sci Med Sci 2004;59:755–761.
  83. Seguin R, Nelson ME: The benefits of strength training for older adults. Am J Prev Med 2003;25(3 suppl 2):141–149.
  84. Petrovitch H, White LR, Ross GW, et al: Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. Neurology 2001;57:226–234.
  85. Troncoso JC, Martin LJ, Dal Forno G, Kawas CH: Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging. Neurobiol Aging 1996;17:365–371.
  86. Lim A, Tsuang D, Kukull W, et al: Clinico-neuropathological correlation of Alzheimer’s disease in a community-based case series. J Am Geriatr Soc 1999;47:564–569.
  87. Massoud F, Devi G, Stern Y, et al: A clinicopathological comparison of community-based and clinic-based cohorts of patients with dementia. Arch Neurol 1999;56:1368–1373.
  88. Snowdon DA, Kemper SJ, Mortimer JA, Greiner LH, Wekstein DR, Markesbery WR: Linguistic ability in early life and cognitive function and Alzheimer’s disease in late life. Findings from the Nun Study. JAMA 1996;275:528–532.
  89. Mortimer JA, Snowdon DA, Markesbery WR: Head circumference, education and risk of dementia: findings from the Nun Study. J Clin Exp Neuropsychol 2003;25:671–679.
  90. Wilson RS, Bienias JL, Evans DA, Bennett DA: The Religious Orders Study: Overview and relation between change in cognitive and motor speed. Aging Neuropsychol Cog 2004;11:280–303.

    External Resources

  91. Mortimer JA, Gosche KM, Riley KP, Markesbery WR, Snowdon DA: Delayed recall, hippocampal volume and Alzheimer neuropathology: findings from the Nun Study. Neurology 2004;62:428–432.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50